oral version of semaglutide A new Wegovy has been FDA-approved, offering a more affordable and accessible option to injectable GLP-1 medications that have transformed weight loss treatment for millions. Read the full story Oral Semaglutide, the First Ingestible

Our team will try to help you at any point in your case, but the sooner you contact us, the more we can do to help you

At 24 weeks post-cessation: Tapered group: regained 8.2% of body weight Abrupt cessation group: regained 9.7% of body weight Difference: 1.5 percentage points (not statistically significant, p = 0.18) However, the tapered group reported significantly lower hunger scores in weeks 1 to 4 post-cessation (mean visual analog scale score 6.2 vs 7.8, p = 0.003)

Current research on the relative benefits and safety of non-FDA approved alternatives compared to the more expensive agents may help improve access to GLP-1 agonists.

L.TenaG.SheenJ

GLP-1 is used in studies on GLP-1R receptor activation, cAMP/PKA signaling pathways in pancreatic beta cell models, and in experiments on incretin metabolism